TY  - JOUR
AU  - Fernández-Gómez, Beatriz
AU  - Marchena,  Miguel A
AU  - Piñeiro, David
AU  - Gómez-Martín, Paula
AU  - Sánchez,  Estefanía
AU  - Laó, Yolanda
AU  - Valencia,  Gloria
AU  - Nocera, Sonia
AU  - Benítez-Fernández, Rocío
AU  - Castaño-León, Ana M
AU  - Lagares, Alfonso
AU  - Hernández Jiménez, Macarena
AU  - Castro, Fernando de
PY  - 2023
DO  - 10.1111/bph.16399
SN  - 0007-1188
UR  - https://hdl.handle.net/20.500.14352/113252
T2  - Br J Pharmacol
AB  - Background and purpose: ApTOLL is an aptamer selected to antagonize toll-like receptor 4 (TLR4), a relevant actor for innate immunity involved in inflammatory responses in multiple sclerosis (MS) and other diseases. The currently available therapeutic...
LA  - eng
M2  - 3263
KW  - OPC
KW  - TLR4
KW  - aptámero
KW  - inmunomodulación
KW  - mielina
KW  - neuroprotección
KW  - oligodendrocito.
TI  - ApTOLL: A new therapeutic aptamer for cytoprotection and (re)myelination after multiple sclerosis
TY  - journal article
VL  - 181
ER  -